A novel data-mining approach leveraging social media to monitor consumer opinion of sitagliptin.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 25561458.
- Also identified by DOI 10.1109/JBHI.2013.2295834.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A novel data mining method was developed to gauge the experience of the drug Sitagliptin (trade name Januvia) by patients with diabetes mellitus type 2. To this goal, we devised a two-step analysis framework. Initial exploratory analysis using self-organizing maps was performed to determine structures based on user opinions among the forum posts. The results were a compilation of user's clusters and their correlated (positive or negative) opinion of the drug. Subsequent modeling using network analysis methods was used to determine influential users among the forum members. These findings can open new avenues of research into rapid data collection, feedback, and analysis that can enable improved outcomes and solutions for public health and important feedback for the manufacturer.
Medical subject headings
- Attitude to Health
- Data Mining
- Diabetes Mellitus, Type 2
- Patient Satisfaction
- Pyrazines
- Social Media
- Triazoles